Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Stablecoin Development Corporation trades on NYSE American under the ticker SDEV. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks SDEV has traded between 0.7800 $ and 99.75 $. As of 09 October 2026 the price stood 2.02 % of the way from the 52-week low to the high.
Over one year SDEV shares fell 54.43 %; over six months they rose 59.77 %. Volatility over 90 days is 246.30 %. Dividends are not included: this is price change only, as of 09 October 2026.
Stablecoin Development Corporation reported revenue of 10M $ and net income of 523M $ over the last four quarters. Revenue changed by +390.34 % year over year.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 07 October 2026 | 3.27 | 3.31 | 2.66 | 2.78 | 25M |
| 06 October 2026 | 3.48 | 4.43 | 3.04 | 3.25 | 64M |
| 05 October 2026 | 9.71 | 9.82 | 3.25 | 3.94 | 88M |
| 02 October 2026 | 5.06 | 7.65 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Stablecoin Development Corporation (SDEV) is a public company in the healthcare sector. Its common stock trade on NYSE American.
Over the trailing twelve months as reported to 2025-12-31, revenue was 9.8m $, net income was -22.1m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA, 94608, US
SDEV has a return on equity of 376.44 %, above the sector median of −41.68 %. Return on assets is 290.74 %, above the sector median of −32.11 %.
| 1.1B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 921M |
| ABTAbbott Laboratories | 99.03 | +0.55 % | 909M |
| BMYBristol-Myers Squibb Company | 59.14 | −0.74 % | 697M |
| REGNRegeneron Pharmaceuticals, Inc. | 747.71 | +1.10 % | 567M |
| 4.98 |
| 7.48 |
| 153M |
| 01 October 2026 | 3.60 | 4.54 | 3.40 | 3.66 | 108M |
| 30 September 2026 | 2.70 | 3.13 | 2.37 | 2.59 | 29M |
| 29 September 2026 | 1.64 | 3.93 | 1.62 | 3.27 | 193M |
| 28 September 2026 | 1.74 | 1.79 | 1.47 | 1.57 | 15M |
| 25 September 2026 | 1.58 | 1.83 | 1.40 | 1.49 | 14M |
| 24 September 2026 | 1.22 | 1.30 | 1.18 | 1.29 | 5M |
| 23 September 2026 | 1.20 | 1.28 | 1.10 | 1.12 | 1M |
| 22 September 2026 | 1.00 | 1.28 | 0.9400 | 1.27 | 2M |
| 21 September 2026 | 1.07 | 1.07 | 0.9600 | 1.00 | 1M |
| 18 September 2026 | 0.8500 | 1.13 | 0.8500 | 1.04 | 3M |
| 17 September 2026 | 0.8200 | 0.9000 | 0.8100 | 0.8400 | 276,400 |
| 16 September 2026 | 0.8600 | 0.8700 | 0.8100 | 0.8400 | 186,600 |
| 15 September 2026 | 0.8800 | 0.9000 | 0.7800 | 0.8600 | 261,200 |
| 14 September 2026 | 0.8700 | 0.8900 | 0.8700 | 0.8800 | 112,000 |
| 11 September 2026 | 0.8700 | 0.9200 | 0.8700 | 0.8900 | 191,200 |
| 10 September 2026 | 0.8700 | 0.8900 | 0.8600 | 0.8600 | 178,300 |